Cardinal Health Inc (CAH)
108.12
+2.12
(+2.00%)
USD |
NYSE |
Apr 19, 16:00
107.00
-1.12
(-1.04%)
After-Hours: 17:33
Cardinal Health Enterprise Value: 25.92B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 25.92B |
| April 17, 2024 | 26.04B |
| April 16, 2024 | 26.20B |
| April 15, 2024 | 26.17B |
| April 12, 2024 | 25.70B |
| April 11, 2024 | 26.02B |
| April 10, 2024 | 26.39B |
| April 09, 2024 | 26.42B |
| April 08, 2024 | 26.76B |
| April 05, 2024 | 26.87B |
| April 04, 2024 | 26.92B |
| April 03, 2024 | 27.12B |
| April 02, 2024 | 27.19B |
| April 01, 2024 | 27.39B |
| March 28, 2024 | 27.35B |
| March 27, 2024 | 27.51B |
| March 26, 2024 | 27.28B |
| March 25, 2024 | 27.14B |
| March 22, 2024 | 27.14B |
| March 21, 2024 | 27.51B |
| March 20, 2024 | 27.35B |
| March 19, 2024 | 27.58B |
| March 18, 2024 | 26.93B |
| March 15, 2024 | 27.04B |
| March 14, 2024 | 26.87B |
| Date | Value |
|---|---|
| March 13, 2024 | 27.15B |
| March 12, 2024 | 28.26B |
| March 11, 2024 | 28.22B |
| March 08, 2024 | 28.15B |
| March 07, 2024 | 27.78B |
| March 06, 2024 | 27.04B |
| March 05, 2024 | 27.60B |
| March 04, 2024 | 27.53B |
| March 01, 2024 | 27.71B |
| February 29, 2024 | 27.37B |
| February 28, 2024 | 27.29B |
| February 27, 2024 | 26.79B |
| February 26, 2024 | 26.96B |
| February 23, 2024 | 26.43B |
| February 22, 2024 | 26.20B |
| February 21, 2024 | 25.81B |
| February 20, 2024 | 25.76B |
| February 16, 2024 | 25.54B |
| February 15, 2024 | 25.66B |
| February 14, 2024 | 25.32B |
| February 13, 2024 | 25.52B |
| February 12, 2024 | 25.34B |
| February 09, 2024 | 25.66B |
| February 08, 2024 | 25.12B |
| February 07, 2024 | 25.84B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.87B
Minimum
Jul 05 2022
28.26B
Maximum
Mar 12 2024
20.50B
Average
19.93B
Median
Enterprise Value Benchmarks
| McKesson Corp | 72.46B |
| Cencora Inc | 49.39B |
| Boston Scientific Corp | 107.39B |
| DaVita Inc | 20.70B |
| Elevance Health Inc | 111.27B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 353.00M |
| Revenue (Quarterly) | 57.44B |
| Total Expenses (Quarterly) | 56.94B |
| EPS Diluted (Quarterly) | 1.43 |
| Gross Profit Margin (Quarterly) | 3.21% |
| Profit Margin (Quarterly) | 0.61% |
| Earnings Yield | 2.35% |
| Operating Earnings Yield | 7.44% |
| Normalized Earnings Yield | 4.840 |